Variant report
Variant | nsv525283 |
---|---|
Chromosome Location | chr7:146406379-146413497 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2533096 | chr7:146406379-146406380 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs6951437 | chr7:146406407-146406408 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs568152055 | chr7:146406414-146406415 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs535595084 | chr7:146406466-146406467 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs138716858 | chr7:146406476-146406477 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs142723028 | chr7:146406486-146406487 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs556878165 | chr7:146406527-146406528 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs565590020 | chr7:146406545-146406546 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs6955893 | chr7:146406579-146406580 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs543044112 | chr7:146406581-146406582 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs369545557 | chr7:146406593-146406594 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs563029123 | chr7:146406608-146406609 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs182193161 | chr7:146406621-146406622 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs549157848 | chr7:146406653-146406654 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs147346381 | chr7:146406680-146406681 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs2533095 | chr7:146406691-146406692 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs551351492 | chr7:146406714-146406715 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs370986591 | chr7:146406717-146406718 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs571584796 | chr7:146406764-146406765 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs537418981 | chr7:146406869-146406870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs551027375 | chr7:146406871-146406872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs567750567 | chr7:146406899-146406900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs536700779 | chr7:146406913-146406914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs370365507 | chr7:146406947-146406948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs553443787 | chr7:146407014-146407015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs374521447 | chr7:146407057-146407058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs138225419 | chr7:146407069-146407070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs539244595 | chr7:146407071-146407072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs558965616 | chr7:146407081-146407082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs575568331 | chr7:146407134-146407135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs543005455 | chr7:146407148-146407149 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs186863627 | chr7:146407223-146407224 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs572907480 | chr7:146407249-146407250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs199765100 | chr7:146407256-146407257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs190754636 | chr7:146407283-146407284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs73168707 | chr7:146407311-146407312 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs182624247 | chr7:146407336-146407337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs528244124 | chr7:146407346-146407347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs545215280 | chr7:146407347-146407348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs565159807 | chr7:146407390-146407391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs530864983 | chr7:146407403-146407404 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs187323295 | chr7:146407420-146407421 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs550988618 | chr7:146407428-146407429 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs73740806 | chr7:146407447-146407448 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs530125946 | chr7:146407465-146407466 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs115051054 | chr7:146407467-146407468 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs144058716 | chr7:146407478-146407479 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs79686326 | chr7:146407535-146407536 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs189836658 | chr7:146407559-146407560 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs67507935 | chr7:146407595-146407596 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Stuttering | 21108403 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17133270 | CNVD |
Schizophrenia | 17646849 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Heart disease | 21282601 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Pancreatitis | 21956041 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Gastric cancer | 16891809 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Cancer | 20164920 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Autism | 20808228 | CNVD |
Schizophrenia | 20838587 | CNVD |
Schizophrenia | 20718829 | CNVD |
Neuropsychiatric disorder | 21827697 | CNVD |
Melanoma | 20877625 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 20964600 | CNVD |
Epilepsy | 17646849 | CNVD |
Mental retardation | 19896112 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Glioma | 20126413 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:146406200-146406400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
2 | chr7:146406200-146406400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr7:146406400-146406800 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr7:146406400-146406800 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr7:146406400-146407000 | Enhancers | Fetal Lung | lung |
6 | chr7:146406400-146407400 | Enhancers | Primary hematopoietic stem cells | blood |
7 | chr7:146406400-146407400 | Enhancers | Ovary | ovary |
8 | chr7:146406400-146407600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
9 | chr7:146406400-146407800 | Enhancers | Stomach Mucosa | stomach |
10 | chr7:146406600-146407400 | Enhancers | Pancreas | Pancrea |
11 | chr7:146406800-146407400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
12 | chr7:146406800-146407400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
13 | chr7:146407400-146407800 | Weak transcription | Ovary | ovary |
14 | chr7:146407400-146407800 | Weak transcription | Pancreas | Pancrea |
15 | chr7:146407800-146408200 | Enhancers | Ovary | ovary |
16 | chr7:146407800-146408200 | Enhancers | Pancreas | Pancrea |
17 | chr7:146410800-146417400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |